Covid
Covid-19: Made-in-India biological E Vaccine may be 90% effective
A top doctor on a government advisory panel says that the biological E’s made-in-India vaccine is expected to have 90 per cent effectiveness against Covid. The doctor added that it will likely be a game changer in the fight against the pandemic.
NK Arora, chairperson of the Centre’s Covid Working Group, has said that the vaccine is entering Phase 3 trials and could be available by October.
Dr Arora, while speaking to NDTV, said Biological E’s vaccine – to be called Corbevax — is similar to the Novavax vaccine, which is more than 90 per cent effective including against Covid variants, according to the company.
Novavax will be produced in India by the Serum Institute of India, which also makes Oxford-AstraZeneca’s Covishield.
The doctor added he believed there is a strong chance that the world will ultimately depend on India for affordable and effective vaccines against COVID-19.